FIA
PFE icon

FNY Investment Advisers’s Pfizer PFE Stock Holding History

FNY Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$5 – 732
2024
Q1 		$5 Buy
200
+2
+1% +$55 ﹤0.01% 524
2023
Q4 		$5K Buy
+198
New +$5.99K 0.01% 353
2020
Q4 		– Sell
-65
Closed -$2K – 881
2020
Q3 		$2K Buy
+65
New +$2.28K ﹤0.01% 418

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

FNY Investment Advisers's PFE Position: Q2 2026 in Review

FNY Investment Advisers increased its Pfizer (PFE) stake by 210% in Q2 2026, buying an estimated $888K and bringing the position to 50,150 shares worth $1.21M. The position accounts for 0.43% of the portfolio, ranked #57.

FNY Investment Advisers first reported a position in PFE in Q4 2019 and has held it in 16 quarters since. 1,698 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • FNY Investment Advisers held 50,150 shares of Pfizer worth $1.21M as of Q2 2026.
  • FNY Investment Advisers bought 33,960 Pfizer shares in Q2 2026, an estimated $888K.
  • Pfizer made up 0.43% of FNY Investment Advisers's portfolio in Q2 2026, its #57 holding.
  • FNY Investment Advisers first reported a position in Pfizer in Q4 2019 and has held it in 16 quarters since.
  • 1,698 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.